| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8432ebff5a06ee8a6ffec8cc7611fbd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2007-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65cc2844ef0da3957ae1729311bea84d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e844ae35aec1c7134df45867a7c78c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd3388e844d9a226c0298de500ca94e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0331ea522981e17e5b76d19dd84d262a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2572f863fab7542c78b11d0cf87fa0b |
| publicationDate |
2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HR-P20070146-B1 |
| titleOfInvention |
NEW PHENYLAMINOPYRIDINE DERIVATIVES AS BCR-ABL KINASE INHIBITORS |
| abstract |
The present invention relates to novel intermediates useful in the preparation of novel phenyl aminopyrimidine derivatives. Pharmaceutical compositions containing novel phenyl aminopyrimidine derivatives and process for their preparation. The present invention relates in particular to novel phenyl aminopyrimidine derivatives of general formula (I). The novel compounds of the formula can be used in the treatment of chronic myeloid leukemia (CML). Because IC; 191 values of the molecules in question range from 0.1 to 10.0 nm, the subject new compounds are potentially useful in the treatment of CML. |
| priorityDate |
2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |